Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luc Biedermann

Showing results (11-20 of 201) with videos related to

Pageof 21
Sort By:
Digestive Diseases (Basel, Switzerland)|January 9, 2013
Environmental factors and their impact on the intestinal microbiota: a role for human disease?Luc Biedermann, Gerhard Rogler
Praxis|July 7, 2016
[Adult Celiac Disease]Natalie Many, Luc Biedermann
Therapeutische Umschau. Revue Therapeutique|November 22, 2017
Tanja Grandinetti, Luc Biedermann
NEJM Evidence|September 23, 2025
Eosinophil in EOE - Not Everything That Counts Can Be Counted and Not Everything That Can Be Counted CountsAlex Straumann, Luc Biedermann
Alimentary Pharmacology & Therapeutics|September 19, 2019
Editorial: anti-TNF therapy-a double-edged sword?Philipp Schreiner, Luc Biedermann
Gastroenterology|April 4, 2021
Defer No Time, Delays Have Dangerous Ends (William Shakespeare)Luc Biedermann, Alex Straumann, Petr Hruz
Praxis|January 29, 2014
[Colitis-associated colorectal carcinoma: epidemiology, pathogenesis and early diagnosis]Michael Scharl, Luc Biedermann, Gerhard Rogler
Digestive Diseases (Basel, Switzerland)|August 23, 2016
The Search for Causative Environmental Factors in Inflammatory Bowel DiseaseGerhard Rogler, Jonas Zeitz, Luc Biedermann
Swiss Medical Weekly|March 23, 2018
New insights into the pathophysiology of inflammatory bowel disease: microbiota, epigenetics and common signalling pathwaysGerhard Rogler, Luc Biedermann, Michael Scharl
Digestive Diseases (Basel, Switzerland)|February 2, 2017
Anti-Cytokine Strategies beyond Anti-Tumour Necrosis Factor-α Therapy: Pathophysiology and Clinical ImplicationsGerhard Rogler, Luc Biedermann, Michael Scharl
Pageof 21

Showing results (11-20 of 201) with videos related to

Sort By:
Pageof 21
Digestive Diseases (Basel, Switzerland)|January 9, 2013
Environmental factors and their impact on the intestinal microbiota: a role for human disease?Luc Biedermann, Gerhard Rogler
Praxis|July 7, 2016
[Adult Celiac Disease]Natalie Many, Luc Biedermann
Therapeutische Umschau. Revue Therapeutique|November 22, 2017
Tanja Grandinetti, Luc Biedermann
NEJM Evidence|September 23, 2025
Eosinophil in EOE - Not Everything That Counts Can Be Counted and Not Everything That Can Be Counted CountsAlex Straumann, Luc Biedermann
Alimentary Pharmacology & Therapeutics|September 19, 2019
Editorial: anti-TNF therapy-a double-edged sword?Philipp Schreiner, Luc Biedermann
Gastroenterology|April 4, 2021
Defer No Time, Delays Have Dangerous Ends (William Shakespeare)Luc Biedermann, Alex Straumann, Petr Hruz
Praxis|January 29, 2014
[Colitis-associated colorectal carcinoma: epidemiology, pathogenesis and early diagnosis]Michael Scharl, Luc Biedermann, Gerhard Rogler
Digestive Diseases (Basel, Switzerland)|August 23, 2016
The Search for Causative Environmental Factors in Inflammatory Bowel DiseaseGerhard Rogler, Jonas Zeitz, Luc Biedermann
Swiss Medical Weekly|March 23, 2018
New insights into the pathophysiology of inflammatory bowel disease: microbiota, epigenetics and common signalling pathwaysGerhard Rogler, Luc Biedermann, Michael Scharl
Digestive Diseases (Basel, Switzerland)|February 2, 2017
Anti-Cytokine Strategies beyond Anti-Tumour Necrosis Factor-α Therapy: Pathophysiology and Clinical ImplicationsGerhard Rogler, Luc Biedermann, Michael Scharl
Pageof 21